Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Medx HealthMDXHF 3-Year ROIIC % is -11.30 as of Dec. 2025. The stock has 8 warning signs investors should review. Among 796 Medical Devices & Instruments companies, Medx Health ranks worse than 65.08% on this metric.
3-Year Return on Invested Incremental Capital (3-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 3-year.
Medx Health's 3-Year ROIIC % for the quarter that ended in Dec. 2025 was -11.30%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
The industry rank for Medx Health's 3-Year ROIIC % or its related term are showing as below:
MDXHF's 3-Year ROIIC % is ranked worse than 65.08% of 796
companies
in the Medical Devices & Instruments industry
Industry Median: 1.52
vs MDXHF: -11.30
Medx Health (OTCPK:MDXHF) 3-Year ROIIC % Explanation
Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.
High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
Be Aware
It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.
Medx Health 3-Year ROIIC % Related Terms
Medx Health 3-Year ROIIC % Historical Data
* Premium members only.
The historical data trend for Medx Health's 3-Year ROIIC % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Medx Health's 3-Year ROIIC %, along with its competitors' market caps and 3-Year ROIIC % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Medx Health 3-Year ROIIC % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Medx Health's 3-Year ROIIC % distribution charts can be found below:
* The bar in red indicates where Medx Health's 3-Year ROIIC % falls into.
Medx Health's 3-Year ROIIC % for the quarter that ended in Dec. 2025 is calculated as:
3-Year ROIIC %
=
3-Year Incremental Net Operating Profit After Taxes (NOPAT)**
/
3-Year Incremental Invested Capital**
=
( -3.111 (Dec. 2025) - -2.847 (Dec. 2022) )
/
( 5.815 (Dec. 2025) - 3.144 (Dec. 2022) )
=
-0.264
/
2.671
=
-9.88%***
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
** Annual data of NOPAT and Invested Capital was used to calculate 3-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.
Medx Health (MDXHF) has a 3-Year ROIIC % of -11.30 as of Dec. 2025. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on Medx Health and its competitors. According to the industry distribution chart, Medx Health ranks #518 out of 796 companies in the Medical Devices & Instruments industry, placing it in the top 65.1%.
Is Medx Health's 3-Year ROIIC % too high?
Medx Health's current 3-Year ROIIC % is -11.30. Based on the distribution chart, Medx Health ranks #518 out of 796 companies in the Medical Devices & Instruments industry, which is below the industry midpoint.
How does Medx Health's 3-Year ROIIC % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Medx Health ranks #518 out of 796 companies for 3-Year ROIIC %. This places Medx Health in the lower half of its industry. The industry median 3-Year ROIIC % is 1.52. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year ROIIC % for a Medical Devices & Instruments company?
The median 3-Year ROIIC % among Medical Devices & Instruments companies is 1.52, based on 796 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year ROIIC % significantly above this median, while those in the bottom quartile fall well below. However, 3-Year ROIIC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year ROIIC % mean?
A high 3-Year ROIIC % can signal that a stock is expensive relative to its fundamentals. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on Medx Health and its competitors. For the Medical Devices & Instruments industry, the median 3-Year ROIIC % is 1.52 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Medx Health's current 3-Year ROIIC % is -11.30. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medx Health stock overvalued right now?
Based on GuruFocus' analysis, Medx Health (MDXHF) is currently considered Significantly Overvalued. The stock's GF Value™ is $0.01, compared to a current price of $0.04 — trading 330% above its estimated fair value. The current 3-Year ROIIC % is -11.30. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year ROIIC % calculated?
3-Year ROIIC % is calculated from a company's financial statements. For Medx Health (MDXHF), the current 3-Year ROIIC % is -11.30 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Medx Health Corp is engaged in the development, manufacturing, and marketing skin-related screening tools and phototherapy devices for pain relief and tissue repair, marketing the latter in Canada and the United States while the skin related screening tools are also marketed in Europe, Australia and selected markets in Latin America. It offers DermSecure, and MedX Laser Therapy.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MDXHF has been successfully added to your 
